APA-viite

Nagaraju, K., Ghimbovschi, S., Rayavarapu, S., Phadke, A., Rider, L. G., Hoffman, E. P., & Miller, F. W. (2016). Muscle myeloid type I interferon gene expression may predict therapeutic responses to rituximab in myositis patients. Rheumatology (Oxford).

Chicago-tyylinen lähdeviittaus

Nagaraju, Kanneboyina, Svetlana Ghimbovschi, Sree Rayavarapu, Aditi Phadke, Lisa G. Rider, Eric P. Hoffman, ja Frederick W. Miller. "Muscle Myeloid Type I Interferon Gene Expression May Predict Therapeutic Responses to Rituximab in Myositis Patients." Rheumatology (Oxford) 2016.

MLA-viite

Nagaraju, Kanneboyina, et al. "Muscle Myeloid Type I Interferon Gene Expression May Predict Therapeutic Responses to Rituximab in Myositis Patients." Rheumatology (Oxford) 2016.

Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.